1. Siragusa S, Cosmi B, Piovella F, Hirsh J, Ginsberg S (1996) Low-molecular-weight heparins and unfractionated heparin in the treatment of patients with acute venous thromboembolism: results of a meta-analysis. J Am Med 100:269–277
2. Folkman J, Langer R, Linhardt RJ, Haudenschild C, Taylor S (1983) Angiogenesis inhibition and tumor regression caused by heparin or a heparin fragment in the presence of cortisone. Science 221:719–725
3. Norrby K (1993) Heparin and angiogenesis: A low-molecular-weight fraction inhibits and a high-molecular-weight fraction stimulates angiogenesis systemically. Haemostasis 23(suppl 1):141–149
4. Bitan M, Mohsen M, Levi E, Wygoda MR, Miao H, Lider O, Svahn CM, Ekre HP, Ishai-Michaeli R, Bar-Shavit R, Vlodavsky I, Peretz T (1995) Structural requirements for inhibition of melanoma lung colonization by heparanase inhibiting species of heparin. Isr J Med Sci 31:106–118
5. Collen A, Smorenburg SM, Peters E, Lupu F, Koolwijk P, van Noordan C, van Hinsbergh VWM (2000) Unfractionated and low molecular weight heparin affect fibrin structure and angiogenisis in vitro. Cancer Res 60:6196–6200